FDA Follows Up Shelhigh Seizure With Formal Request For Recall
This article was originally published in The Gray Sheet
Executive Summary
FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month